Study Data Show Abbott ' s CardioMEMSDevice Can Improve Care for More Patients with Heart Failure

ABBOTT PARK, Ill., Aug. 27, 2021.  Abbott today announced results of the landmark GUIDE-HF clinical trial, a 1,000 patient randomized study designed to assess the benefits of the CardioMEMS HF System in people living with NYHA Class II, III and...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials